Add Company
Join Now

ARK Diagnostics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • ARK Diagnostics's estimated annual revenue is currently $12M per year.(i)
  • ARK Diagnostics's estimated revenue per employee is $251,000

Employee Data

  • ARK Diagnostics has 48 Employees.(i)
  • ARK Diagnostics grew their employee count by 4% last year.

ARK Diagnostics's People

NameTitleEmail/Phone
1
Director Product DevelopmentReveal Email/Phone
2
Senior Manager, Marketing and ServiceReveal Email/Phone
3
Sales ConsultantReveal Email/Phone
4
Scientist IReveal Email/Phone
5
R&D Scientist IReveal Email/Phone
6
Pharmaceutical Sciences Specialist IIReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
R&D Research AssociateReveal Email/Phone
9
Associate Scientist 1Reveal Email/Phone
10
Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is ARK Diagnostics?

ARK Diagnostics Inc. designs, manufactures, and distributes in vitro diagnostic products. ARK’s proprietary assays accurately measure drug levels in biological fluids. Clinicians use these measurements to guide dosing decisions for safe, effective, and personalized drug therapy. By optimizing drug levels, clinicians improve outcomes, reduce toxicity, and lower healthcare costs. ARK is dedicated to improving the quality of patient health through better therapeutic drug management. (ARK Diagnostics, Inc. seeks regulatory clearance in the United States and Internationally.)

keywords:N/A

N/A

Total Funding

48

Number of Employees

$12M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M48-11%N/A
#2
$10.4M487%N/A
#3
$5.6M4841%N/A
#4
$6.9M48-8%N/A
#5
$7.5M480%$242.6M